These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22917938)

  • 21. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
    Wang D; Xu J; Feng Y; Liu Y; Mchenga SS; Shan F; Sasaki J; Lu C
    Vaccine; 2010 Apr; 28(18):3134-42. PubMed ID: 20197133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
    Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A
    FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccine constructs expressing Mycobacterium tuberculosis-specific genes induce immune responses.
    Hanif SN; Al-Attiyah R; Mustafa AS
    Scand J Immunol; 2010 Nov; 72(5):408-15. PubMed ID: 21039735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli.
    Brun P; Zumbo A; Castagliuolo I; Delogu G; Manfrin F; Sali M; Fadda G; Grillot-Courvalin C; Palù G; Manganelli R
    Vaccine; 2008 Apr; 26(16):1934-41. PubMed ID: 18342411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH; Sun Z; Yang XL; Bao L
    Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.
    Wang QM; Sun SH; Hu ZL; Yin M; Xiao CJ; Zhang JC
    Vaccine; 2004 Sep; 22(27-28):3622-7. PubMed ID: 15315841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector.
    Huang JM; Sali M; Leckenby MW; Radford DS; Huynh HA; Delogu G; Cranenburgh RM; Cutting SM
    Vaccine; 2010 Nov; 28(47):7523-8. PubMed ID: 20851079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH; Bercovier H
    Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
    Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
    Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge.
    Park SU; Kathaperumal K; McDonough S; Akey B; Huntley J; Bannantine JP; Chang YF
    Vaccine; 2008 Aug; 26(34):4329-37. PubMed ID: 18582521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.